Guidance Documents

This guidance document addresses whether a Drug Enforcement Administration (DEA) registrant who is an authorized collector has the responsibility to file a Report of Theft or Loss of Controlled Substances (DEA Form 106) if a sealed inner liner is stolen, lost, or missing while in a common or contract carrier’s custody.

This guidance document addresses whether a sealed inner liner may be transported by employees of a Drug Enforcement Administration (DEA) registrant authorized as a collector, or after pick-up by a common courier driver, to a common carrier storefront/franchise prior to the common carrier transporting the sealed inner liner to a reverse distributor for destruction.

This document explains how various federal nondiscrimination laws, including the Americans with Disabilities Act, Section 504 of the Rehabilitation Act of 1973, Title VI of the Civil Rights Act of 1964, and Section 1557 of the Patient Protection and Affordable Care Act, can help to ensure that services provided via telehealth are accessible to people with disabilities and limited English proficient persons. 

This manual is intended to summarize and explain the basic requirements for administering and dispensing (but not prescribing) narcotic controlled substances approved by the Food and Drug Administration (FDA) specifically for use in maintenance or detoxification treatment in a DEA registered NTP under subchapter I (Control and Enforcement) of the CSA and DEA regulations, 21 CFR Parts 1300 to End.

A guidance document that provides a broad overview of how employers’ use of artificial intelligence, algorithms, and other technologies in hiring and employment may result in unlawful discrimination against people with disabilities under Title I of the Americans with Disabilities Act (ADA).

The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) recently examined devices commonly known as “forced reset triggers” (FRTs) and has determined that some of them are “firearms” and “machineguns” as defined in the National Firearms Act (NFA), and “machineguns” as defined in the Gun Control Act (GCA).

This manual was prepared by the Drug Enforcement Administration (DEA), Diversion Control Division, to assist those persons who handle scheduled listed chemical products and List I and II chemicals in understanding the Federal Controlled Substances Act and its implementing regulations as they pertain to regulated chemicals.

This Q&A addresses the intersection of heath care entities’ COVID-19 era “visitor” policies and their intersection with the entities’ existing ADA obligations. 

This guidance document addresses how a Drug Addiction Treatment Act of 2000 (DATA)-waived practitioner may request removal of the X Number assigned to the provider’s DEA registration when they no longer intend to administer, dispense or prescribe buprenorphine to treat opioid use disorder and do not need the waiver.

This fact sheet, issued jointly with the Office for Civil Rights of the Department of Education, provides information about federal civil rights laws that protect students with mental health disabilities at risk of self-harm in the era of COVID-19. 

Template letter explaining process and documentation requested for remote quality of service reviews of approved credit counseling agencies

The purpose of this letter is to provide guidance on your obligations as a federal firearms licensee (FFL) in Colorado. The following guidance is intended to assist you in accomplishing this goal.